NCT05709353: MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
- State
- State not given
- Phase
- Phase 2
- People
- 120 planned
- Started
- 19 Sep 2023
- Primary completion
- May 2026
- Arms
- COPE + MDMA
- Results
- None posted
- 2 Feb 2023: Trial registered
- 19 Sep 2023: Trial started